SG48816A1 - Gonococcal anti-idiotypic antibodies and methods and compositions using them - Google Patents

Gonococcal anti-idiotypic antibodies and methods and compositions using them

Info

Publication number
SG48816A1
SG48816A1 SG1996001965A SG1996001965A SG48816A1 SG 48816 A1 SG48816 A1 SG 48816A1 SG 1996001965 A SG1996001965 A SG 1996001965A SG 1996001965 A SG1996001965 A SG 1996001965A SG 48816 A1 SG48816 A1 SG 48816A1
Authority
SG
Singapore
Prior art keywords
idiotypic antibodies
compositions
methods
gonococcal
relates
Prior art date
Application number
SG1996001965A
Other languages
English (en)
Inventor
Peter A Rice
Sunita Gulati
Daniel P Mcquillen
Original Assignee
Trustees Of Health & Hospitals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trustees Of Health & Hospitals filed Critical Trustees Of Health & Hospitals
Publication of SG48816A1 publication Critical patent/SG48816A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG1996001965A 1993-04-06 1994-04-06 Gonococcal anti-idiotypic antibodies and methods and compositions using them SG48816A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/043,663 US5476784A (en) 1993-04-06 1993-04-06 Gonococcal anti-idiotypic antibodies and methods and compositions using them

Publications (1)

Publication Number Publication Date
SG48816A1 true SG48816A1 (en) 1998-05-18

Family

ID=21928258

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001965A SG48816A1 (en) 1993-04-06 1994-04-06 Gonococcal anti-idiotypic antibodies and methods and compositions using them

Country Status (11)

Country Link
US (4) US5476784A (de)
EP (1) EP0695192B1 (de)
CN (1) CN1118299C (de)
AT (1) ATE199321T1 (de)
AU (1) AU698908B2 (de)
CA (1) CA2164123A1 (de)
DE (1) DE69426767D1 (de)
NZ (1) NZ265000A (de)
OA (1) OA10187A (de)
SG (1) SG48816A1 (de)
WO (1) WO1994022479A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
US5674493A (en) * 1993-08-31 1997-10-07 Thomas Jefferson University Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5612030A (en) 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US6074641A (en) * 1995-06-07 2000-06-13 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
EP1030684A4 (de) * 1997-11-14 2004-09-15 Euro Celtique Sa Modifizierte antikörper mit verstärkter fähigkeit eine anti-idiotypische antwort auszulösen
US6645503B1 (en) * 1998-03-10 2003-11-11 Wyeth Holdings Corporation Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
US7189405B1 (en) * 1999-10-29 2007-03-13 Rice Peter A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
CN1409725B (zh) * 1999-10-29 2012-06-06 彼得·A·赖斯 保守淋球菌表位的拟肽及应用它们的方法和组合物
US6801270B2 (en) * 2000-06-26 2004-10-05 Reveo, Inc. Backlight for a liquid crystal display having high light-recycling efficiency
FR2858326A1 (fr) * 2003-08-01 2005-02-04 Abtech Procede de preparation d'anticorps mimetiques d'une substance et les anticorps ainsi obtenus
US20060073534A1 (en) * 2004-10-05 2006-04-06 The University Of Georgia Research Foundation, Inc Method for cleaving and deglycosylating antibodies to promote ligand binding
GB0819633D0 (en) * 2008-10-25 2008-12-03 Isis Innovation Composition
WO2021061676A1 (en) 2019-09-23 2021-04-01 University Of Massachusetts Multi-antigenic peptide mimics of gonococcal lipo-oligosaccharide (los) epitopes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them

Also Published As

Publication number Publication date
EP0695192A1 (de) 1996-02-07
WO1994022479A1 (en) 1994-10-13
EP0695192B1 (de) 2001-02-28
CA2164123A1 (en) 1994-10-13
ATE199321T1 (de) 2001-03-15
AU6530494A (en) 1994-10-24
US5939067A (en) 1999-08-17
AU698908B2 (en) 1998-11-12
HK1016017A1 (en) 1999-10-22
CN1118299C (zh) 2003-08-20
OA10187A (en) 1996-12-18
US5888509A (en) 1999-03-30
US5476784A (en) 1995-12-19
DE69426767D1 (de) 2001-04-05
CN1124456A (zh) 1996-06-12
US6099839A (en) 2000-08-08
NZ265000A (en) 1997-12-19

Similar Documents

Publication Publication Date Title
IL189629A0 (en) Compositions containing human ctla-4 antibodies
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
MX9706969A (es) 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos.
UA48940C2 (uk) Рекомбінатні il4 антитіла, які використовуються для лікування il4-опосередкованих порушень
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
ZA954679B (en) Bicyclic compounds
GB2301366A (en) Antibodies against E-selectin
NZ324500A (en) Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
PL328858A1 (en) Immunogenous peptides
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
GR3026219T3 (en) Mouse monoclonal antibodies
NL300787I1 (de)
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
ZA943744B (en) Therapeutic substituted guanidines
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
TR199700999T1 (xx) Askomisinler.
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
ES2054484T3 (es) Composiciones farmaceuticas que contienen complejos de antigeno-anticuerpo, asi como la utilizacion de las mismas.
AU641279B2 (en) Oligosaccharide derivatives
CA2192675A1 (en) Methods for treating motor deficits
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.